Rare lephants
Screener

CapsoVision, Inc.

CV ·Healthcare, Medical Devices, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
8-K Sep 28, 2026 8-K
4 Sep 23, 2026 PRIMARY DOCUMENT
4/A Sep 23, 2026 PRIMARY DOCUMENT
4/A Sep 23, 2026 PRIMARY DOCUMENT
4 Sep 18, 2026 PRIMARY DOCUMENT
8-K Sep 18, 2026 8-K
424B5 Sep 18, 2026 424B5
EFFECT Aug 21, 2026
424B5 Aug 21, 2026 424B5
8-K Aug 18, 2026 8-K
S-3 Aug 13, 2026 S-3
10-Q Aug 13, 2026 10-Q
8-K Aug 13, 2026 8-K
4 Jul 21, 2026 PRIMARY DOCUMENT
4 Jul 10, 2026 PRIMARY DOCUMENT
4 Jul 7, 2026 PRIMARY DOCUMENT
4 Jul 2, 2026 FORM 4
3 Jul 2, 2026 FORM 3
8-K Jul 2, 2026 8-K
4 Jul 1, 2026 FORM 4
4/A Jul 1, 2026 FORM 4/A
4 Jul 1, 2026 FORM 4
4 Jul 1, 2026 FORM 4
4 Jul 1, 2026 FORM 4
4 Jul 1, 2026 FORM 4
← Newer Page 1 of 6 · 140 filings Older →